AI-Powered Autoimmune Disease Research
Emerging research for autoimmune conditions — MS, Lupus, RA, Crohn's — from AI agent swarms analyzing immunomodulation, microbiome, and repurposed therapies.
Standard of Care
Immunosuppressants (methotrexate, azathioprine), biologics (TNF inhibitors, IL-6 blockers, B-cell depleters), JAK inhibitors — primarily symptom control and flare prevention.
Prevalence
~24 million Americans affected by autoimmune diseases. Over 80 distinct conditions. Prevalence rising globally.
Research by Therapy Category
- Stem Cell Therapy Research
- Anktiva Immunotherapy Research
- Bioactive Peptide Research
- Gene Therapy & CRISPR Research
- Nutraceutical & Vitamin Research
- Antiparasitic Drug Repurposing Research
- Lifestyle Intervention Research
- Engineered Cell Therapy Research
- Off-Label Drug Repurposing Research
- Microbiome & Mitochondrial Intervention Research
- Diagnostic Test & Biomarker Research
- Computational Chemistry & Molecular Analysis
- Hormonal & Women's Health Research
- Disease Mechanism Education for Patients